A unified cell biological perspective on axon-myelin injury

Journal of Cell Biology

Volumn 206, Issue 3, 2014, Pages 335-345

  Simons, Mikael ^a,b   Misgeld, Thomas ^c,d,e   Kerschensteiner, Martin ^e,f  

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

^e Technische Universität München Munich Cluster for Systems Neurology   (Germany)

^f UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN;

CYTOPATHOLOGY; HUMAN; IMMUNOCOMPETENT CELL; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE CELL DEGENERATION; NERVE FIBER; NERVE FIBER DEGENERATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; REVIEW; WALLERIAN DEGENERATION;

ANIMALS; AXONS; DEMYELINATING DISEASES; DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; NERVE DEGENERATION; OLIGODENDROGLIA;

EID: 84905982538     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201404154     Document Type: Review

References (111)

1. Aboul-Enein, F., H. Rauschka, B. Kornek, C. Stadelmann, A. Stefferl, W. Brück, C. Lucchinetti, M. Schmidbauer, K. Jellinger, and H. Lassmann. 2003. Preferential loss of myelin-associated glycoprotein reflects hypoxialike white matter damage in stroke and inflammatory brain diseases. J. Neuropathol. Exp. Neurol. 62:25-33.
2. Aggarwal, S., L. Yurlova, and M. Simons. 2011. Central nervous system myelin: structure, synthesis and assembly. Trends Cell Biol. 21:585-593. http:// dx.doi.org/10.1016/j.tcb.2011.06.004
3. Aggarwal, S., N. Snaidero, G. Pähler, S. Frey, P. Sánchez, M. Zweckstetter, A. Janshoff, A. Schneider, M.T. Weil, I.A. Schaap, et al. 2013. Myelin membrane assembly is driven by a phase transition of myelin basic proteins into a cohesive protein meshwork. PLoS Biol. 11:e1001577. http://dx.doi .org/10.1371/journal.pbio.1001577
4. Arancibia-Carcamo, I.L., and D. Attwell. 2014. The node of Ranvier in CNS pathology. Acta Neuropathol. http://dx.doi.org/10.1007/s00401-014-1305-z
5. Arthur-Farraj, P., R. Mirsky, D.B. Parkinson, and K.R. Jessen. 2006. A double point mutation in the DNA-binding region of Egr2 switches its function from inhibition to induction of proliferation: A potential contribution to the development of congenital hypomyelinating neuropathy. Neurobiol. Dis. 24:159-169. http://dx.doi.org/10.1016/j.nbd.2006.06.006
6. Babetto, E., B. Beirowski, E.V. Russler, J. Milbrandt, and A. DiAntonio. 2013. The Phr1 ubiquitin ligase promotes injury-induced axon self-destruction. Cell Reports. 3:1422-1429. http://dx.doi.org/10.1016/j.celrep.2013.04.013
7. Bartzokis, G. 2011. Alzheimer's disease as homeostatic responses to agerelated myelin breakdown. Neurobiol. Aging. 32:1341-1371. http://dx.doi .org/10.1016/j.neurobiolaging.2009.08.007
8. Berthold, C.H., and R.I. Nilsson. 2002. De- and remyelination in spinal roots during normal perinatal development in the cat: a brief summary of structural observations and a conceptual hypothesis. J. Anat. 200:391-403. http://dx.doi.org/10.1046/j.1469-7580.2002.00042.x
9. Bishop, D.L., T. Misgeld, M.K. Walsh, W.B. Gan, and J.W. Lichtman. 2004. Axon branch removal at developing synapses by axosome shedding. Neuron. 44:651-661. http://dx.doi.org/10.1016/j.neuron.2004.10.026
10. Bjartmar, C., G. Kidd, S. Mörk, R. Rudick, and B.D. Trapp. 2000. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients. Ann. Neurol. 48:893-901. http://dx.doi .org/10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.0.CO;2-B
11. Bø L., C.A. Vedeler, H.I. Nyland, B.D. Trapp, and S.J. Mørk. 2003. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62:723-732.
12. Bosboom, W.M., L.H. van den Berg, H. Franssen, P.C. Giesbergen, H.Z. Flach, A.M. van Putten, H. Veldman, and J.H. Wokke. 2001. Diagnostic value of sural nerve demyelination in chronic inflammatory demyelinating polyneuropathy. Brain. 124:2427-2438. http://dx.doi.org/10.1093/brain/ 124.12.2427
13. Bouchard, C., C. Lacroix,V. Planté D. Adams, F. Chedru, J.M. Guglielmi, and G. Said. 1999. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 52:498-503. http:// dx.doi.org/10.1212/WNL.52.3.498
14. Cantuti Castelvetri, L., M.I. Givogri, A. Hebert, B. Smith, Y. Song, A. Kaminska, A. Lopez-Rosas, G. Morfini, G. Pigino, M. Sands, et al. 2013. The sphingolipid psychosine inhibits fast axonal transport in Krabbe disease by activation of GSK3β and deregulation of molecular motors. J. Neurosci. 33:10048-10056. http://dx.doi.org/10.1523/JNEUROSCI.0217-13.2013
15. Carmeli, C., A. Donati, V. Antille, D. Viceic, J. Ghika, A. von Gunten, S. Clarke, R. Meuli, R.S. Frackowiak, and M.G. Knyazeva. 2013. Demyelination in mild cognitive impairment suggests progression path to Alzheimer's disease. PLoS ONE. 8:e72759. http://dx.doi.org/10.1371/journal.pone.0072759
16. Chitnis, T., J. Imitola, Y. Wang, W. Elyaman, P. Chawla, M. Sharuk, K. Raddassi, R.T. Bronson, and S.J. Khoury. 2007. Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration. Am. J. Pathol. 170:1695-1712. http://dx.doi.org/10.2353/ajpath .2007.060677
17. Chong, S.Y., S.S. Rosenberg, S.P. Fancy, C. Zhao, Y.A. Shen, A.T. Hahn, A.W. McGee, X. Xu, B. Zheng, L.I. Zhang, et al. 2012. Neurite outgrowth inhibitor Nogo-A establishes spatial segregation and extent of oligodendrocyte myelination. Proc. Natl. Acad. Sci. USA. 109:1299-1304. http://dx.doi.org/10.1073/pnas.1113540109
18. Coleman, M.P., and M.R. Freeman. 2010. Wallerian degeneration, wld(s), and nmnat. Annu. Rev. Neurosci. 33:245-267. http://dx.doi.org/10.1146/ annurev-neuro-060909-153248
19. Coleman, M.P., L. Conforti, E.A. Buckmaster, A. Tarlton, R.M. Ewing, M.C. Brown, M.F. Lyon, and V.H. Perry. 1998. An 85-kb tandem triplication in the slow Wallerian degeneration (Wlds) mouse. Proc. Natl. Acad. Sci. USA. 95:9985-9990. http://dx.doi.org/10.1073/pnas.95.17.9985
20. Coleman, M.P., R. Adalbert, and B. Beirowski. 2005. Neuroprotective strategies in MS: lessons from C57BL/Wld(S) mice. J. Neurol. Sci. 233:133-138. http://dx.doi.org/10.1016/j.jns.2005.03.028
21. Conforti, L., A. Tarlton, T.G. Mack, W. Mi, E.A. Buckmaster, D. Wagner, V.H. Perry, and M.P. Coleman. 2000. A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse. Proc. Natl. Acad. Sci. USA. 97:11377-11382. http://dx.doi.org/10 .1073/pnas.97.21.11377
22. Czopka, T., C. Ffrench-Constant, and D.A. Lyons. 2013. Individual oligodendrocytes have only a few hours in which to generate new myelin sheaths in vivo. Dev. Cell. 25:599-609. http://dx.doi.org/10.1016/j.devcel.2013.05.013
23. Davalos, D., J. Grutzendler, G. Yang, J.V. Kim, Y. Zuo, S. Jung, D.R. Littman, M.L. Dustin, and W.B. Gan. 2005. ATP mediates rapid microglial response to local brain injury in vivo. Nat. Neurosci. 8:752-758. http:// dx.doi.org/10.1038/nn1472
24. Derfuss, T., K. Parikh, S. Velhin, M. Braun, E. Mathey, M. Krumbholz, T. Kümpfel, A. Moldenhauer, C. Rader, P. Sonderegger, et al. 2009. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals. Proc. Natl. Acad. Sci. USA. 106:8302-8307. http://dx.doi.org/10.1073/pnas.0901496106
25. De Stefano, N., S. Narayanan, G.S. Francis, R. Arnaoutelis, M.C. Tartaglia, J.P. Antel, P.M. Matthews, and D.L. Arnold. 2001. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch. Neurol. 58:65-70. http://dx.doi.org/10.1001/archneur.58.1.65
26. Dziedzic, T., I. Metz, T. Dallenga, F.B. Künig, S. Müller, C. Stadelmann, and W. Brück. 2010. Wallerian degeneration: a major component of early axonal pathology in multiple sclerosis. Brain Pathol. 20:976-985.
27. Edgar, J.M., M. McLaughlin, H.B. Werner, M.C. McCulloch, J.A. Barrie, A. Brown, A.B. Faichney, N. Snaidero, K.A. Nave, and I.R. Griffiths. 2009. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. Glia. 57:1815-1824. http://dx.doi.org/ 10.1002/glia.20893
28. Feinberg, K., Y. Eshed-Eisenbach, S. Frechter, V. Amor, D. Salomon, H. Sabanay, J.L. Dupree, M. Grumet, P.J. Brophy, P. Shrager, and E. Peles. 2010. A glial signal consisting of gliomedin and NrCAM clusters axonal Na + channels during the formation of nodes of Ranvier. Neuron. 65:490-502. http://dx.doi.org/10.1016/j.neuron.2010.02.004
29. Fischer, L.R., D.G. Culver, P. Tennant, A.A. Davis, M. Wang, A. Castellano-Sanchez, J. Khan, M.A. Polak, and J.D. Glass. 2004. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 185:232-240. http://dx.doi.org/10.1016/j.expneurol.2003.10.004
30. Frühbeis, C., D. Fröhlich, W.P. Kuo, J. Amphornrat, S. Thilemann, A.S. Saab, F. Kirchhoff, W. Möbius, S. Goebbels, K.A. Nave, et al. 2013. Neurotransmitter-triggered transfer of exosomes mediates oligodendrocyte-neuron communication. PLoS Biol. 11:e1001604. http://dx.doi. org/10.1371/journal.pbio.1001604
31. Fünfschilling, U., L.M. Supplie, D. Mahad, S. Boretius, A.S. Saab, J. Edgar, B.G. Brinkmann, C.M. Kassmann, I.D. Tzvetanova, W. Möbius, et al. 2012. Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature. 485:517-521.
32. Ghosh, A., N. Manrique-Hoyos, A. Voigt, J.B. Schulz, M. Kreutzfeldt, D. Merkler, and M. Simons. 2011. Targeted ablation of oligodendrocytes triggers axonal damage. PLoS ONE. 6:e22735. http://dx.doi.org/10.1371/ journal.pone.0022735
33. Gilley, J., and M.P. Coleman. 2010. Endogenous Nmnat2 is an essential survival factor for maintenance of healthy axons. PLoS Biol. 8:e1000300. http:// dx.doi.org/10.1371/journal.pbio.1000300
34. Gillingwater, T.H., and R.R. Ribchester. 2001. Compartmental neurodegeneration and synaptic plasticity in the Wld(s) mutant mouse. J. Physiol. 534:627-639. http://dx.doi.org/10.1111/j.1469-7793.2001.00627.x
35. Gillingwater, T.H., and R.R. Ribchester. 2003. The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J. Neurocytol. 32:863-881. http://dx .doi.org/10.1023/B:NEUR.0000020629.51673.f5
36. Hametner, S., I. Wimmer, L. Haider, S. Pfeifenbring, W. Brück, and H. Lassmann. 2013. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74:848-861. http://dx.doi.org/10.1002/ana.23974
37. Han, X., M. Chen, F. Wang, M. Windrem, S. Wang, S. Shanz, Q. Xu, N.A. Oberheim, L. Bekar, S. Betstadt, et al. 2013. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell. 12:342-353. http://dx.doi.org/ 10.1016/j.stem.2012.12.015
38. Harrisingh, M.C., E. Perez-Nadales, D.B. Parkinson, D.S. Malcolm, A.W. Mudge, and A.C. Lloyd. 2004. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J. 23:3061-3071. http://dx .doi.org/10.1038/sj.emboj.7600309
39. Hirokawa, N., S. Niwa, and Y. Tanaka. 2010. Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron. 68:610-638. http://dx.doi.org/10.1016/j.neuron.2010.09.039
40. Hoopfer, E.D., T. McLaughlin, R.J. Watts, O. Schuldiner, D.D. O'Leary, and L. Luo. 2006. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning. Neuron. 50:883- 895. http://dx.doi.org/10.1016/j.neuron.2006.05.013
41. Hughes, E.G., S.H. Kang, M. Fukaya, and D.E. Bergles. 2013. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat. Neurosci. 16:668-676. http://dx.doi.org/10.1038/nn.3390
42. Jung, J., W. Cai, H.K. Lee, M. Pellegatta, Y.K. Shin, S.Y. Jang, D.J. Suh, L. Wrabetz, M.L. Feltri, and H.T. Park. 2011. Actin polymerization is essential for myelin sheath fragmentation during Wallerian degeneration. J. Neurosci. 31:2009-2015. http://dx.doi.org/10.1523/JNEUROSCI .4537-10.2011
43. Kaneko, S., J. Wang, M. Kaneko, G. Yiu, J.M. Hurrell, T. Chitnis, S.J. Khoury, and Z. He. 2006. Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models. J. Neurosci. 26:9794-9804. http://dx.doi.org/10 .1523/JNEUROSCI.2116-06.2006
44. Kerschensteiner, M., M.E. Schwab, J.W. Lichtman, and T. Misgeld. 2005. In vivo imaging of axonal degeneration and regeneration in the injured spinal cord. Nat. Med. 11:572-577. http://dx.doi.org/10.1038/nm1229
45. Kirby, B.B., N. Takada, A.J. Latimer, J. Shin, T.J. Carney, R.N. Kelsh, and B. Appel. 2006. In vivo time-lapse imaging shows dynamic oligodendrocyte progenitor behavior during zebrafish development. Nat. Neurosci. 9:1506-1511. http://dx.doi.org/10.1038/nn1803
46. Köller, H., B.C. Kieseier, S. Jander, and H.P. Hartung. 2005. Chronic inflammatory demyelinating polyneuropathy. N. Engl. J. Med. 352:1343-1356. http://dx.doi.org/10.1056/NEJMra041347
47. Kuchibhotla, K.V., C.R. Lattarulo, B.T. Hyman, and B.J. Bacskai. 2009. Synchronous hyperactivity and intercellular calcium waves in astrocytes in Alzheimer mice. Science. 323:1211-1215. http://dx.doi.org/10 .1126/science.1169096
48. Kuhlmann, T., G. Lingfeld, A. Bitsch, J. Schuchardt, and W. Brück. 2002. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain. 125:2202-2212. http://dx.doi.org/ 10.1093/brain/awf235
49. Kutzelnigg, A., C.F. Lucchinetti, C. Stadelmann, W. Brück, H. Rauschka, M. Bergmann, M. Schmidbauer, J.E. Parisi, and H. Lassmann. 2005. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 128:2705-2712. http://dx.doi.org/10.1093/brain/awh641
50. Kuwabara, S., and N. Yuki. 2013. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol. 12:1180-1188. http://dx.doi.org/10.1016
51. Lappe-Siefke, C., S. Goebbels, M. Gravel, E. Nicksch, J. Lee, P.E. Braun, I.R. Griffiths, and K.A. Nave. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination. Nat. Genet. 33:366-374. http://dx.doi.org/10.1038/ng1095
52. Lassmann, H., U. Bartsch, D. Montag, and M. Schachner. 1997. Dying-back oligodendrogliopathy: a late sequel of myelin-associated glycoprotein deficiency. Glia. 19:104-110. http://dx.doi.org/10.1002/(SICI)1098-1136(199702)19:2<104::AID-GLIA2>3.0.CO;2-0
53. Lassmann, H., J. van Horssen, and D. Mahad. 2012. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 8:647-656. http:// dx.doi.org/10.1038/nrneurol.2012.168
54. Lee, Y., B.M. Morrison, Y. Li, S. Lengacher, M.H. Farah, P.N. Hoffman, Y. Liu, A. Tsingalia, L. Jin, P.W. Zhang, et al. 2012. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature. 487:443-448. http://dx.doi.org/10.1038/nature11314
55. Liu, P., J.L. Du, and C. He. 2013. Developmental pruning of early-stage myelin segments during CNS myelination in vivo. Cell Res. 23:962-964. http:// dx.doi.org/10.1038/cr.2013.62
56. Locatelli, G., S. Wörtge, T. Buch, B. Ingold, F. Frommer, B. Sobottka, M. Krüger, K. Karram, C. Bühlmann, I. Bechmann, et al. 2012. Primary oligodendrocyte death does not elicit anti-CNS immunity. Nat. Neurosci. 15:543-550. http://dx.doi.org/10.1038/nn.3062
57. Lubetzki, C., and B. Stankoff. 2014. Demyelination in multiple sclerosis. Handb. Clin. Neurol. 122:89-99. http://dx.doi.org/10.1016/B978-0-444-52001-2.00004-2
58. Lubińska, L. 1982. Patterns of Wallerian degeneration of myelinated fibres in short and long peripheral stumps and in isolated segments of rat phrenic nerve. Interpretation of the role of axoplasmic flow of the trophic factor. Brain Res. 233:227-240. http://dx.doi.org/10.1016/0006-8993(82)91199-4
59. Lucchinetti, C., W. Brück, J. Parisi, B. Scheithauer, M. Rodriguez, and H. Lassmann. 2000. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann. Neurol. 47:707-717. http://dx .doi.org/10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q
60. Ludwin, S.K., and E.S. Johnson. 1981. Evidence for a "dying-back" gliopathy in demyelinating disease. Ann. Neurol. 9:301-305. http://dx.doi. org/10.1002/ana.410090316
61. Lunn, E.R., V.H. Perry, M.C. Brown, H. Rosen, and S. Gordon. 1989. Absence of Wallerian degeneration does not hinder regeneration in peripheral nerve. Eur. J. Neurosci. 1:27-33. http://dx.doi.org/10.1111/j.1460-9568 .1989.tb00771.x
62. Luo, L., and D.D. O'Leary. 2005. Axon retraction and degeneration in development and disease. Annu. Rev. Neurosci. 28:127-156. http://dx.doi.org/10 .1146/annurev.neuro.28.061604.135632
63. MacDonald, J.M., M.G. Beach, E. Porpiglia, A.E. Sheehan, R.J. Watts, and M.R. Freeman. 2006. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons. Neuron. 50:869-881. http:// dx.doi.org/10.1016/j.neuron.2006.04.028
64. Martin, S.M., G.S. O'Brien, C. Portera-Cailliau, and A. Sagasti. 2010. Wallerian degeneration of zebrafish trigeminal axons in the skin is required for regeneration and developmental pruning. Development. 137:3985-3994. http://dx.doi.org/10.1242/dev.053611
65. Mathey, E.K., T. Derfuss, M.K. Storch, K.R. Williams, K. Hales, D.R. Woolley, A. Al-Hayani, S.N. Davies, M.N. Rasband, T. Olsson, et al. 2007. Neurofascin as a novel target for autoantibody-mediated axonal injury. J. Exp. Med. 204:2363-2372. http://dx.doi.org/10.1084/jem.20071053
66. Miller, B.R., C. Press, R.W. Daniels, Y. Sasaki, J. Milbrandt, and A. DiAntonio. 2009. A dual leucine kinase-dependent axon self-destruction program promotes Wallerian degeneration. Nat. Neurosci. 12:387-389. http://dx.doi .org/10.1038/nn.2290
67. Miron, V.E., A. Boyd, J.W. Zhao, T.J. Yuen, J.M. Ruckh, J.L. Shadrach, P. van Wijngaarden, A.J. Wagers, A. Williams, R.J. Franklin, and C. ffrench-Constant. 2013. M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination. Nat. Neurosci. 16:1211-1218. http://dx.doi.org/10.1038/nn.3469
68. Mishra, B., R. Carson, R.I. Hume, and C.A. Collins. 2013. Sodium and potassium currents influence Wallerian degeneration of injured Drosophila axons. J. Neurosci. 33:18728-18739. http://dx.doi.org/10.1523/JNEUROSCI .1007-13.2013
69. Möbius, W., B. Cooper, W.A. Kaufmann, C. Imig, T. Ruhwedel, N. Snaidero, A.S. Saab, and F. Varoqueaux. 2010. Electron microscopy of the mouse central nervous system. Methods Cell Biol. 96:475-512. http://dx.doi .org/10.1016/S0091-679X(10)96020-2
70. Musse, A.A., W. Gao, L. Homchaudhuri, J.M. Boggs, and G. Harauz. 2008. Myelin basic protein as a "PI(4,5)P2-modulin": a new biological function for a major central nervous system protein. Biochemistry. 47:10372- 10382. http://dx.doi.org/10.1021/bi801302b
71. Napoli, I., L.A. Noon, S. Ribeiro, A.P. Kerai, S. Parrinello, L.H. Rosenberg, M.J. Collins, M.C. Harrisingh, I.J. White, A. Woodhoo, and A.C. Lloyd. 2012. A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron. 73:729-742. http://dx.doi.org/10.1016/j.neuron.2011.11.031
72. Nave, K.A. 2010. Myelination and the trophic support of long axons. Nat. Rev. Neurosci. 11:275-283. http://dx.doi.org/10.1038/nrn2797
73. Nawaz, S., A. Kippert, A.S. Saab, H.B. Werner, T. Lang, K.A. Nave, and M. Simons. 2009. Phosphatidylinositol 4,5-bisphosphate-dependent interaction of myelin basic protein with the plasma membrane in oligodendroglial cells and its rapid perturbation by elevated calcium. J. Neurosci. 29:4794-4807. http://dx.doi.org/10.1523/JNEUROSCI.3955-08.2009
74. Nayak, D., T.L. Roth, and D.B. McGavern. 2014. Microglia development and function. Annu. Rev. Immunol. 32:367-402. http://dx.doi.org/10.1146/ annurev-immunol-032713-120240
75. Nikić, I., D. Merkler, C. Sorbara, M. Brinkoetter, M. Kreutzfeldt, F.M. Bareyre, W. Brück, D. Bishop, T. Misgeld, and M. Kerschensteiner. 2011. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat. Med. 17:495-499. http://dx.doi.org/ 10.1038/nm.2324
76. Oluich, L.J., J.A. Stratton, Y.L. Xing, S.W. Ng, H.S. Cate, P. Sah, F. Windels, T.J. Kilpatrick, and T.D. Merson. 2012. Targeted ablation of oligodendrocytes induces axonal pathology independent of overt demyelination. J. Neurosci. 32:8317-8330. http://dx.doi.org/10.1523/JNEUROSCI.1053-12.2012
77. Orthmann-Murphy, J.L., M. Freidin, E. Fischer, S.S. Scherer, and C.K. Abrams. 2007. Two distinct heterotypic channels mediate gap junction coupling between astrocyte and oligodendrocyte connexins. J. Neurosci. 27:13949- 13957. http://dx.doi.org/10.1523/JNEUROSCI.3395-07.2007
78. Osterloh, J.M., J. Yang, T.M. Rooney, A.N. Fox, R. Adalbert, E.H. Powell, A.E. Sheehan, M.A. Avery, R. Hackett, M.A. Logan, et al. 2012. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 337:481-484. http://dx.doi.org/10.1126/science.1223899
79. Pohl, H.B., C. Porcheri, T. Mueggler, L.C. Bachmann, G. Martino, D. Riethmacher, R.J. Franklin, M. Rudin, and U. Suter. 2011. Genetically induced adult oligodendrocyte cell death is associated with poor myelin clearance, reduced remyelination, and axonal damage. J. Neurosci. 31:1069-1080. http://dx.doi.org/10.1523/JNEUROSCI.5035-10.2011
80. Pröbstel, A.K., K. Dornmair, R. Bittner, P. Sperl, D. Jenne, S. Magalhaes, A. Villalobos, C. Breithaupt, R. Weissert, U. Jacob, et al. 2011. Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology. 77:580-588. http://dx.doi.org/10.1212/WNL.0b013e318228c0b1
81. Raff, M.C., A.V. Whitmore, and J.T. Finn. 2002. Axonal self-destruction and neurodegeneration. Science. 296:868-871. http://dx.doi.org/10.1126/ science.1068613
82. Rasband, M.N., J. Tayler, Y. Kaga, Y. Yang, C. Lappe-Siefke, K.A. Nave, and R. Bansal. 2005. CNP is required for maintenance of axon-glia interactions at nodes of Ranvier in the CNS. Glia. 50:86-90. http://dx.doi.org/ 10.1002/glia.20165
83. Reimer, M.M., J. McQueen, L. Searcy, G. Scullion, B. Zonta, A. Desmazieres, P.R. Holland, J. Smith, C. Gliddon, E.R. Wood, et al. 2011. Rapid disruption of axon-glial integrity in response to mild cerebral hypoperfusion. J. Neurosci. 31:18185-18194. http://dx.doi.org/10.1523/JNEUROSCI .4936-11.2011
84. Rodriguez, M. 1992. Central nervous system demyelination and remyelination in multiple sclerosis and viral models of disease. J. Neuroimmunol. 40:255-263. http://dx.doi.org/10.1016/0165-5728(92)90141-7
85. Rodriguez, M., and B. Scheithauer. 1994. Ultrastructure of multiple sclerosis. Ultrastruct. Pathol. 18:3-13. http://dx.doi.org/10.3109/01913129409016267
86. Romanelli, E., C.D. Sorbara, I. Nikić, A. Dagkalis, T. Misgeld, and M. Kerschensteiner. 2013. Cellular, subcellular and functional in vivo labeling of the spinal cord using vital dyes. Nat. Protoc. 8:481-490. http:// dx.doi.org/10.1038/nprot.2013.022
87. Salzer, J.L., P.J. Brophy, and E. Peles. 2008. Molecular domains of myelinated axons in the peripheral nervous system. Glia. 56:1532-1540. http:// dx.doi.org/10.1002/glia.20750
88. Schaefer, A.M., J.R. Sanes, and J.W. Lichtman. 2005. A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol. 490:209-219. http://dx.doi.org/10.1002/cne.20620
89. Schain, A.J., R.A. Hill, and J. Grutzendler. 2014. Label-free in vivo imaging of myelinated axons in health and disease with spectral confocal reflectance microscopy. Nat. Med. 20:443-449. http://dx.doi.org/10 .1038/nm.3495
90. Schaumburg, H.H., H.M. Wiśniewski, and P.S. Spencer. 1974. Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication. J. Neuropathol. Exp. Neurol. 33:260-284. http://dx.doi.org/10.1097/00005072-197404000-00006
91. Schirmer, L., J.P. Antel, W. Brück, and C. Stadelmann. 2011. Axonal loss and neurofilament phosphorylation changes accompany lesion development and clinical progression in multiple sclerosis. Brain Pathol. 21:428-440. http://dx.doi.org/10.1111/j.1750-3639.2010.00466.x
92. Sherman, D.L., S. Tait, S. Melrose, R. Johnson, B. Zonta, F.A. Court, W.B. Macklin, S. Meek, A.J. Smith, D.F. Cottrell, and P.J. Brophy. 2005. Neurofascins are required to establish axonal domains for saltatory conduction. Neuron. 48:737-742. http://dx.doi.org/10.1016/j.neuron.2005.10.019
93. Simons, M., N. Snaidero, and S. Aggarwal. 2012. Cell polarity in myelinating glia: from membrane flow to diffusion barriers. Biochim. Biophys. Acta. 1821:1146-1153. http://dx.doi.org/10.1016/j.bbalip.2012.01.011
94. Singh, S., I. Metz, S. Amor, P. van der Valk, C. Stadelmann, and W. Bruück. 2013. Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathol. 125:595-608. http://dx.doi .org/10.1007/s00401-013-1082-0
95. Snaidero, N., W. Möbius, T. Czopka, L.H. Hekking, C. Mathisen, D. Verkleij, S. Goebbels, J. Edgar, D. Merkler, D.A. Lyons, et al. 2014. Myelin membrane wrapping of CNS axons by PI(3,4,5)P3-dependent polarized growth at the inner tongue. Cell. 156:277-290. http://dx.doi.org/ 10.1016/j.cell.2013.11.044
96. Stys, P.K. 2005. General mechanisms of axonal damage and its prevention. J. Neurol. Sci. 233:3-13. http://dx.doi.org/10.1016/j.jns.2005.03.031
97. Susuki, K., K.J. Chang, D.R. Zollinger, Y. Liu, Y. Ogawa, Y. Eshed-Eisenbach, M.T. Dours-Zimmermann, J.A. Oses-Prieto, A.L. Burlingame, C.I.Seidenbecher, et al. 2013. Three mechanisms assemble central nervous system nodes of Ranvier. Neuron. 78:469-482. http://dx.doi.org/10.1016/ j.neuron.2013.03.005
98. Tomassy, G.S., D.R. Berger, H.H. Chen, N. Kasthuri, K.J. Hayworth, A. Vercelli, H.S. Seung, J.W. Lichtman, and P. Arlotta. 2014. Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex. Science. 344:319-324. http://dx.doi.org/10.1126/science.1249766
99. Toyama, B.H., J.N. Savas, S.K. Park, M.S. Harris, N.T. Ingolia, J.R. Yates III, and M.W. Hetzer. 2013. Identification of long-lived proteins reveals exceptional stability of essential cellular structures. Cell. 154:971-982. http://dx.doi.org/10.1016/j.cell.2013.07.037
100. Traka, M., L. Goutebroze, N. Denisenko, M. Bessa, A. Nifli, S. Havaki, Y. Iwakura, F. Fukamauchi, K. Watanabe, B. Soliven, et al. 2003. Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J. Cell Biol. 162:1161-1172. http://dx.doi.org/10.1083/jcb.200305078
101. Traka, M., K. Arasi, R.L. Avila, J.R. Podojil, A. Christakos, S.D. Miller, B. Soliven, and B. Popko. 2010. A genetic mouse model of adult-onset, pervasive central nervous system demyelination with robust remyelination. Brain. 133:3017-3029. http://dx.doi.org/10.1093/brain/awq247
102. Trapp, B.D., and P.K. Stys. 2009. Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol. 8:280-291. http:// dx.doi.org/10.1016/S1474-4422(09)70043-2
103. Trapp, B.D., J. Peterson, R.M. Ransohoff, R. Rudick, S. Mörk, and L. Bö 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278-285. http://dx.doi.org/10.1056/NEJM199801293380502
104. Vargas, M.E., and B.A. Barres. 2007. Why is Wallerian degeneration in the CNS so slow? Annu. Rev. Neurosci. 30:153-179. http://dx.doi.org/10.1146/ annurev.neuro.30.051606.094354
105. Viader, A., Y. Sasaki, S. Kim, A. Strickland, C.S. Workman, K. Yang, R.W. Gross, and J. Milbrandt. 2013. Aberrant Schwann cell lipid metabolism linked to mitochondrial deficits leads to axon degeneration and neuropathy. Neuron. 77:886-898. http://dx.doi.org/10.1016/j.neuron.2013.01.012
106. Wakatsuki, S., F. Saitoh, and T. Araki. 2011. ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation. Nat. Cell Biol. 13:1415-1423. http://dx.doi.org/10.1038
107. Wang, J.T., Z.A. Medress, and B.A. Barres. 2012. Axon degeneration: Molecular mechanisms of a self-destruction pathway. J. Cell Biol. 196:7-18. http:// dx.doi.org/10.1083/jcb.201108111
108. Weiss, M.D., J. Hammer, and R.H. Quarles. 2000. Oligodendrocytes in aging mice lacking myelin-associated glycoprotein are dystrophic but not apoptotic. J. Neurosci. Res. 62:772-780. http://dx.doi.org/10.1002/1097-4547(20001215)62:6<772::AID-JNR3>3.0.CO;2-X
109. Xiong, X., Y. Hao, K. Sun, J. Li, X. Li, B. Mishra, P. Soppina, C. Wu, R.I. Hume, and C.A. Collins. 2012. The Highwire ubiquitin ligase promotes axonal degeneration by tuning levels of Nmnat protein. PLoS Biol. 10:e1001440. http://dx.doi.org/10.1371/journal.pbio.1001440
110. Zhang, C., K. Susuki, D.R. Zollinger, J.L. Dupree, and M.N. Rasband. 2013. Membrane domain organization of myelinated axons requires ?II spectrin. J. Cell Biol. 203:437-443. http://dx.doi.org/10.1083/jcb.201308116
111. Zhu, X.H., H. Qiao, F. Du, Q. Xiong, X. Liu, X. Zhang, K. Ugurbil, and W. Chen. 2012. Quantitative imaging of energy expenditure in human brain. Neuroimage. 60:2107-2117. http://dx.doi.org/10.1016/j.neuroimage .2012.02.013